Table 3 Past SARS-CoV-2 infection and seroprevalence at baseline sampling for the total population (n=1,226), staff (n=852), and residents (n=374). The SARS-CoV-2 RT-qPCR results between March and August 2020 were self-reported at enrolment. Seroprevalence was assessed at baseline sampling
Prior RT-qPCR result | Baseline Serology | Resident (n=374) | Staff (n=852) | Total (n=1,226) |
|---|---|---|---|---|
Positive | Positive | 93 (25.1%) | 304 (35.6%) | 397 (32.4%) |
Positive | Negative | 19 (5.1%) | 42 (4.9%) | 61 (4.9%) |
Negative | Positive | 76 (20.5%) | 106 (12.4%) | 182 (14.8%) |
Negative | Negative | 183 (49.3%) | 403 (49.3%) | 586 (47.8%) |